Suanfarma Suanfarma

X

Find Pradigastat manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Pradigastat
Also known as: Lcq-908, 956136-95-1, Lcq908, Pradigastat free acid, Lcq-908nxa, Lcq908-nxa
Molecular Formula
C25H24F3N3O2
Molecular Weight
455.5  g/mol
InChI Key
GXALXAKNHIROPE-UHFFFAOYSA-N
FDA UNII
2U23G6VNUZ

Pradigastat has been used in trials studying the treatment of Non-alcoholic Fatty Liver Disease (NAFLD).
1 2D Structure

Pradigastat

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[4-[4-[5-[[6-(trifluoromethyl)pyridin-3-yl]amino]pyridin-2-yl]phenyl]cyclohexyl]acetic acid
2.1.2 InChI
InChI=1S/C25H24F3N3O2/c26-25(27,28)23-12-10-21(15-30-23)31-20-9-11-22(29-14-20)19-7-5-18(6-8-19)17-3-1-16(2-4-17)13-24(32)33/h5-12,14-17,31H,1-4,13H2,(H,32,33)
2.1.3 InChI Key
GXALXAKNHIROPE-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1CC(CCC1CC(=O)O)C2=CC=C(C=C2)C3=NC=C(C=C3)NC4=CN=C(C=C4)C(F)(F)F
2.2 Other Identifiers
2.2.1 UNII
2U23G6VNUZ
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Lcq908

2.3.2 Depositor-Supplied Synonyms

1. Lcq-908

2. 956136-95-1

3. Lcq908

4. Pradigastat Free Acid

5. Lcq-908nxa

6. Lcq908-nxa

7. Lcq-908-nxa

8. 2u23g6vnuz

9. Lcq908 - Dgat-1-inhibitor

10. 956136-95-1 (free Acid)

11. Pradigastat (usan)

12. Lcq 908

13. Pradigastat [usan]

14. 2-((1s,4s)-4-(4-(5-((6-(trifluoromethyl)pyridin-3-yl)amino)pyridin-2-yl)phenyl)cyclohexyl)acetic Acid

15. 2-[4-[4-[5-[[6-(trifluoromethyl)pyridin-3-yl]amino]pyridin-2-yl]phenyl]cyclohexyl]acetic Acid

16. 2-{4-[4-(5-{[6-(trifluoromethyl)pyridin-3-yl]amino}pyridin-2-yl)phenyl]cyclohexyl}acetic Acid

17. Pradigastat [inn]

18. Pradigastat [usan:inn]

19. Unii-2u23g6vnuz

20. Lcq 908nxa

21. Schembl180536

22. Gtpl7830

23. Schembl1289309

24. Chembl2364624

25. Schembl16104874

26. Schembl18286769

27. Dtxsid401026085

28. Bcp21089

29. Lcq908; Lcq 908; Pradigastat

30. Bdbm50502586

31. Zinc253387875

32. Cs-1222

33. Db12866

34. Sb16971

35. Ncgc00378933-01

36. Ncgc00378933-02

37. Hy-16278

38. Db-125833

39. D10664

40. A900338

41. Q27088438

42. (4-{4-[5-(6-trifluoromethyl-pyridin-3-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic Acid

43. Cyclohexaneacetic Acid, 4-(4-(5-((6-(trifluoromethyl)-3-pyridinyl)amino)-2-pyridinyl)phenyl)-, Trans-

44. Lcq-908; Trans-4-[4-[5-[[6-(trifluoromethyl)-3-pyridinyl]amino]-2-pyridinyl]phenyl]cyclohexaneacetic Acid;lcq-908

45. Trans-4-[4-[5-[[6-(trifluoromethyl)-3-pyridinyl]amino]-2-pyridinyl]phenyl]cyclohexaneacetic Acid

2.4 Create Date
2011-10-17
3 Chemical and Physical Properties
Molecular Weight 455.5 g/mol
Molecular Formula C25H24F3N3O2
XLogP35.7
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count8
Rotatable Bond Count6
Exact Mass455.18206150 g/mol
Monoisotopic Mass455.18206150 g/mol
Topological Polar Surface Area75.1 Ų
Heavy Atom Count33
Formal Charge0
Complexity631
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Treatment of familial chylomicronaemia syndrome (type I hyperlipoproteinaemia


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY